TrialJAMA ophthalmology2016

Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.

Eric L Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.